Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ChIPseq of IMR32 cells treated with ISX or solvent control

ABSTRACT: ChIPseq of IMR32 cells treated with ISX or solvent control

PROVIDER: PRJEB52347 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

ChIPseq of IMR32 cells treated with ISX or solvent control

Project description:IMR32 cells were treated with DMSO/ISX and Histone code and MycN binding was assessed via ChIPseq.

2023-01-17 | E-MTAB-12344 | biostudies-arrayexpress

ChIPseq of IMR32 cells treated with ISX or solvent control

Project description:ChIPseq of IMR32 cells treated with ISX or solvent control

| PRJEB57174 | ENA

ATACseq of IMR32 cells treated with ISX or solvent control

Project description:IMR32 cells were treated with DMSO/ISX and open chromatin regions were assessed via ATACseq

2023-01-17 | E-MTAB-11633 | biostudies-arrayexpress

ATACseq of IMR32 cells treated with ISX or solvent control

Project description:ATACseq of IMR32 cells treated with ISX or solvent control

| PRJEB52309 | ENA

Transcriptional changes in IMR32 cells upon ISX treatment

Project description:IMR32 neuroblastoma cells were treated with ISX, a novel GLI1 inducing HDAC-inhibitor

2021-04-28 | E-MTAB-10249 | biostudies-arrayexpress

Transcriptional changes in IMR32 cells upon ISX treatment

Project description:Transcriptional changes in IMR32 cells upon ISX treatment

| PRJEB43754 | ENA

PML1: IMR32 vs empty vector IMR32

Project description:Transcriptional profiling of neuroblastoma cell line expressing the PML1 isoform. Two-condition experiment: PML1 IMR32 vs empty vector IMR32. Two biological replicates, dye-swapped.

2016-08-09 | E-GEOD-78086 | biostudies-arrayexpress

Isx-9 induces enteroendocrine cell differentiation in the intestinal organoids

Project description:We investigated the cell identity and cell proportion in the intestinal organoids treated by Isoxazole-9 (Isx-9) using single-cell transcriptome analysis. Isx-9 enriches enteroendocrine cells without altering the cell identity of other lineages. To investigate the mechanism of this process, we performed RNA-seq and ATAC-seq of Isx-9 treated intestinal stem cells. Based on the gene expression pattern and differential peaks of open chromatin, we found that Isx-9 upregulated neuroendocrine related genes, and elevated the chromatin accessibility at the promoter region of enteroendocrine related transcription factors.

2023-09-05 | GSE183476 | GEO

Global mRNA expression profile in cardiac progenitor cells generated by ISX-9

Project description:We developed a strategy to generate cardiac progenitor cells from human induced pluripotent stem cells using a novel small molecule. mRNA-sequencing results showed different gene expression profile among undifferentiated human induced pluripotent stem cells(hiPSCs), DMSO and ISX-9 treated hiPSCs.In comparsion with DMSO treated cells or undifferentiated hiPSCs, ISX-9 upregulated the genes related to WNT and cytoskeleton remodeling and TGF-β signaling, which are involved in heart development and cardiac differentiation. In addition, the genes related to cardiac differentiation signaling pathways were upregulated by ISX-9 including development of PIP3 signaling in cardiomyocyte myocytes, muscle contraction and NF-AT hypertrophy signaling.

2017-12-30 | GSE95389 | GEO

Transcriptional changes in MCF7 cells upon ISX treatment

Project description:MCF7 cells were treated with ISX, a novel GLI1 inducing HDAC-inhibitor

2021-04-28 | E-MTAB-10248 | biostudies-arrayexpress